{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:00:15Z","timestamp":1790787615387,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10067-021-05724-5","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T10:03:56Z","timestamp":1617789836000},"page":"3015-3019","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?"],"prefix":"10.1007","volume":"40","author":[{"given":"Diana","family":"Castillo-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaira","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6258-5732","authenticated-orcid":false,"given":"Luis M.","family":"Amezcua-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0544-7461","authenticated-orcid":false,"given":"Carlos","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"5724_CR1","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061\u20131069","journal-title":"JAMA"},{"key":"5724_CR2","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382:e38","journal-title":"N Engl J Med"},{"key":"5724_CR3","unstructured":"https:\/\/www.hematology.org\/covid-19\/covid-19-and-apl-ab. Accessed 7 Dec 2020"},{"key":"5724_CR4","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s10067-020-05275-1","volume":"39","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Zimba O, Gasparyan AY (2020) Thrombosis in coronavirus disease 2019 (COVID-19) through the prism of Virchow\u2019s triad. Clin Rheumatol 39:2529\u20132543","journal-title":"Clin Rheumatol"},{"key":"5724_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.thromres.2020.05.017","volume":"192","author":"F Galeano-Valle","year":"2020","unstructured":"Galeano-Valle F, Oblitas CM, Ferreiro-Maz\u00f3n MM et al (2020) Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism. Thromb Res 192:113\u2013115","journal-title":"Thromb Res"},{"key":"5724_CR6","doi-asserted-by":"publisher","unstructured":"Pineton de Chambrun M, Frere C et al (2020) High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: A link with hypercoagulability? J Intern Med. https:\/\/doi.org\/10.1111\/joim.13126","DOI":"10.1111\/joim.13126"},{"key":"5724_CR7","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1590\/1806-9282.66.11.1595","volume":"66","author":"A Funke","year":"2020","unstructured":"Funke A, Staub HL, Monticielo OA et al (2020) Non-criteria antiphospholipid antibodies: A narrative review. Rev Assoc Med Bras 66:1595\u20131601","journal-title":"Rev Assoc Med Bras"},{"key":"5724_CR8","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1111\/jth.14867","volume":"18","author":"I Harzallah","year":"2020","unstructured":"Harzallah I, Debliquis A, Dr\u00e9nou B (2020) Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost 18:2064\u20132065","journal-title":"J Thromb Haemost"},{"key":"5724_CR9","doi-asserted-by":"publisher","unstructured":"Amezcua-Guerra LM, Rojas-Velasco G, Brianza-Padilla M et al (2020) Presence of antiphospholipid antibodies in COVID-19: Case series study. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218100","DOI":"10.1136\/annrheumdis-2020-218100"},{"key":"5724_CR10","doi-asserted-by":"publisher","unstructured":"Zuo Y, Estes SK, Ali RA et al (2020) Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.abd3876","DOI":"10.1126\/scitranslmed.abd3876"},{"key":"5724_CR11","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.41425","volume":"72","author":"M Xiao","year":"2020","unstructured":"Xiao M, Zhang Y, Zhang S et al (2020) Antiphospholipid antibodies in critically ill patients with COVID-19. Arthritis Rheum 72:1998\u20132004","journal-title":"Arthritis Rheum"},{"key":"5724_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s11239-020-02182-9","volume":"50","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Cao W, Jiang W et al (2020) Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients. J Thromb Thrombolysis 50:580\u2013586","journal-title":"J Thromb Thrombolysis"},{"key":"5724_CR13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1111\/jth.14994","volume":"18","author":"KMJ Devreese","year":"2020","unstructured":"Devreese KMJ, Linskens EA, Benoit D, Peperstraete H (2020) Antiphospholipid antibodies in patients with COVID-19: A relevant observation? J Thromb Haemost 18:2191\u20132201","journal-title":"J Thromb Haemost"},{"key":"5724_CR14","first-page":"754","volume":"38","author":"M Gatto","year":"2020","unstructured":"Gatto M, Perricone C, Tonello M et al (2020) Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: Findings from a multicentre study on 122 cases. Clin Exp Rheumatol 38:754\u2013759","journal-title":"Clin Exp Rheumatol"},{"issue":"Supl","key":"5724_CR15","first-page":"84","volume":"90","author":"LM Amezcua-Guerra","year":"2020","unstructured":"Amezcua-Guerra LM (2020) Brief annotations on cytokine release syndrome and interleukin-6 therapeutic blockage in SARS-CoV-2\/COVID-19. Arch Cardiol Mex 90(Supl):84\u201387","journal-title":"Arch Cardiol Mex"},{"key":"5724_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquard C, Severac F et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med 46:1089\u20131098","journal-title":"Intensive Care Med"},{"key":"5724_CR17","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1111\/ijlh.13320","volume":"42","author":"X Guti\u00e9rrez L\u00f3pez de Oc\u00e1riz","year":"2020","unstructured":"Guti\u00e9rrez L\u00f3pez de Oc\u00e1riz X, Castro Quismondo N, Vera Guerrero E, Rodr\u00edguez Rodr\u00edguez M, Ayala D\u00edaz R, Mart\u00ednez L\u00f3pez J (2020) Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19). Int J Lab Hematol 42:e280\u2013e282","journal-title":"Int J Lab Hematol"},{"key":"5724_CR18","doi-asserted-by":"publisher","first-page":"e017773","DOI":"10.1161\/JAHA.120.017773","volume":"9","author":"E Ferrari","year":"2020","unstructured":"Ferrari E, Sartre B, Squara F et al (2020) High prevalence of acquired thrombophilia without prognosis value in patients with coronavirus disease 2019. J Am Heart Assoc 9:e017773","journal-title":"J Am Heart Assoc"},{"key":"5724_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJMc2013656","volume":"383","author":"L Bowles","year":"2020","unstructured":"Bowles L, Platton S, Yartey N et al (2020) Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. N Engl J Med 383:288\u2013290","journal-title":"N Engl J Med"},{"key":"5724_CR20","doi-asserted-by":"publisher","first-page":"e2017539","DOI":"10.1001\/jamanetworkopen.2020.17539","volume":"3","author":"M Reyes Gil","year":"2020","unstructured":"Reyes Gil M, Barouqa M, Szymanski J, Gonzalez-Lugo JD, Rahman S, Billett HH (2020) Assessment of lupus anticoagulant positivity in patients with coronavirus disease 2019 (COVID-19). JAMA Netw Open 3:e2017539","journal-title":"JAMA Netw Open"},{"key":"5724_CR21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3389\/fneur.2020.00806","volume":"11","author":"S Fan","year":"2020","unstructured":"Fan S, Xiao M, Han F et al (2020) Neurological manifestations in critically ill patients with COVID-19: A retrospective study. Front Neurol 11:806","journal-title":"Front Neurol"},{"key":"5724_CR22","doi-asserted-by":"publisher","first-page":"102719","DOI":"10.1016\/j.autrev.2020.102729","volume":"20","author":"A Le Joncour","year":"2021","unstructured":"Le Joncour A, Frere C, Martin-Toutain I et al (2021) Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward. Autoimmun Rev 20:102719","journal-title":"Autoimmun Rev"},{"key":"5724_CR23","doi-asserted-by":"publisher","unstructured":"Pascolini S, Vannini A, Deleonardi G et al (2020) COVID-19 and immunological dysregulation: Can autoantibodies be useful? Clin Transl Sci. https:\/\/doi.org\/10.1111\/cts.12908","DOI":"10.1111\/cts.12908"},{"key":"5724_CR24","doi-asserted-by":"publisher","first-page":"584241","DOI":"10.3389\/fimmu.2020.584241","volume":"11","author":"MO Borghi","year":"2020","unstructured":"Borghi MO, Beltagy A, Garrafa E et al (2020) Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome. Front Immunol 11:584241","journal-title":"Front Immunol"},{"key":"5724_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.thromres.2020.07.016","volume":"195","author":"V Siguret","year":"2020","unstructured":"Siguret V, Voicu S, Neuwirth M et al (2020) Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? Thromb Res 195:74\u201376","journal-title":"Thromb Res"},{"key":"5724_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","volume":"220","author":"C Magro","year":"2020","unstructured":"Magro C, Mulvey JJ, Berlin D et al (2020) Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res 220:1\u201313","journal-title":"Transl Res"},{"key":"5724_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.thromres.2018.11.003","volume":"172","author":"V Pengo","year":"2018","unstructured":"Pengo V, Del Ross T, Ruffatti A et al (2018) Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns. Thromb Res 172:172\u2013178","journal-title":"Thromb Res"},{"key":"5724_CR28","doi-asserted-by":"publisher","unstructured":"Hasan Ali O, Bomze D, Risch L et al (2020) COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa1496","DOI":"10.1093\/cid\/ciaa1496"},{"key":"5724_CR29","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/art.39187","volume":"67","author":"L Andreoli","year":"2015","unstructured":"Andreoli L, Chighizola CB, Nalli C et al (2015) Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against \u03b22-glycoprotein I domain 1 and domain 4\/5: Ratio of anti-domain 1 to anti-domain 4\/5 as a useful new biomarker for antiphospholipid syndrome. Arthritis Rheum 67:2196\u20132204","journal-title":"Arthritis Rheum"},{"key":"5724_CR30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/0961203312438116","volume":"21","author":"PL Meroni","year":"2012","unstructured":"Meroni PL, Raschi E, Grossi C et al (2012) Obstetric and vascular APS: Same autoantibodies but different diseases? Lupus 21:708\u2013710","journal-title":"Lupus"},{"key":"5724_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295\u2013306","journal-title":"J Thromb Haemost"},{"key":"5724_CR32","doi-asserted-by":"publisher","unstructured":"Gkrouzman E, Barbhaiya M, Erkan D, Lockshin MD (2020) Reality check on antiphospholipid antibodies in COVID-19-associated coagulopathy. Arthritis Rheum. https:\/\/doi.org\/10.1002\/art.41472","DOI":"10.1002\/art.41472"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05724-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05724-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05724-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T16:14:19Z","timestamp":1623255259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05724-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5724"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05724-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}